首页> 外文OA文献 >PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UK

【2h】

PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UK

机译：PIN19英国的23价肺炎球菌多糖疫苗（PPV23）与13价肺炎球菌共轭疫苗（PCV13）接种老年人和高危人群的预算影响（BI）分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jiang Y.; Gauthier A.; Keeping S.T.; Carroll S.M.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK [J] . JiangY., GauthierA., KeepingS., Expert review of pharmacoeconomics & outcomes research . 2014,第6期

机译：英国对老年人和高危成年人接种23价肺炎球菌多糖疫苗或13价肺炎球菌结合疫苗的公共卫生和预算影响分析
2. Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK [J] . JiangY., GauthierA., KeepingS., Expert review of pharmacoeconomics & outcomes research . 2014,第6期

机译：在英国为老年人和高危成年人接种23价肺炎球菌多糖疫苗或13价肺炎球菌结合疫苗的成本效益
3. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults >= 65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine [J] . Peterson James T., Stacey Helen L., MacNair John E., Human vaccines & immunotherapeutics. . 2019,第3期

机译：15价肺炎球菌缀合物疫苗的安全性和免疫原性与成人中的13价肺炎球菌缀合物疫苗> = 65岁以前用23价肺炎球菌多糖疫苗接种疫苗
4. Evaluation of the effectiveness of a 13-valent pneumococcal conjugated vaccine implemented in the municipality of Campos de Goytacazes, Brazil [C] . Kury C.M.H., Vitral C.L, Kury M.M.H., World Congress of the World Society for Pediatric Infectious Diseases . 2014

机译：评估在巴西坎波德·戈科塔斯市政府实施的13价肺炎球菌共轭疫苗的有效性
5. Response to Pneumococcal-Polysaccharide Vaccine PPV23 in HIV-Positive Individuals [D] . Iyer, Anita Sridhar. 2015

机译：HIV阳性人群对肺炎球菌多糖疫苗PPV23的反应
6. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine [O] . James T. Peterson, Helen L. Stacey, John E. MacNair, 2019

机译：15价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗相比在先前接种过23价肺炎球菌多糖疫苗的65岁以上成年人中的安全性和免疫原性
7. PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UK [O] . Y. Jiang, A. Gauthier, S.T. Keeping, 2012

机译：与英国13价肺炎球菌缀合物疫苗（PCV13）或英国没有疫苗（Novac）相比，评估疫苗的成本效果（CE）与23价肺炎球菌多糖疫苗（PPV23）疫苗接种的成本效果（CE）

PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UK

著录项

引文网络

相似文献

相关主题

期刊订阅